Sign in
4

Changes in Ownership

Medtronic plc Filed Acc 0001613103-25-000003

EVP & Pres Neuroscience sold 9,850 shares at $80.41 ($792,039)

  • EVP & Pres Neuroscience acquired 6,850 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wall Brett A. EVP & Pres Neuroscience 2025-01-08 Option exercise 10b5-1 +6,850 $74.84 $512,654 50,558 D: show line 1 in the form
Wall Brett A. EVP & Pres Neuroscience 2025-01-08 Sale 10b5-1 −6,850 $80.41 $550,809 43,708 D: show line 2 in the form
Wall Brett A. EVP & Pres Neuroscience 2025-01-08 Sale 10b5-1 −3,000 $80.41 $241,230 40,708 D: show line 3 in the form
Open-market sales · 9,850 sh · avg $80.41 · $792,039

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Wall Brett A. EVP & Pres Neuroscience 2025-01-08 Option exercise · Stock Option (Right to Buy) 10b5-1 −6,850 0 D: show line 4 in the form
Loading xslF345X05/wk-form4_1736545728.xml…